Tag: Bayer

Bayer AG is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer’s primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers.

Elanco Animal Health Entered into Definitive Agreement to Acquire Bayer’s Animal Health Business

U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business. The transaction is valued at 7.6 billion U.S. dollars consisting of 5.3 billi...

Bayer Announced Acquiring of BlueRock Therapeutics

Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engi...

NICE Recommended Bayer’s Xarelto for Preventing Atherothrombotic Events

Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in high-risk adults with coronary artery disease, NICE has said. In the final draft guidance, NICE recomm...

FDA Approved Bayer’s Non-Steroidal Androgen Receptor Inhibitor

The U.S. Food and Drug Administration (FDA) has approved darolutamide, a non-steroidal androgen receptor inhibitor (ARi), under the brand name Nubeqa®. The FDA approval is for the treatment of pati...

Bayer and WRA Renewed Partnership to Improve Every Day Health of Women, Infants and Children

bayer
Bayer and White Ribbon Alliance (WRA) announced they will extend their partnership and expand their initiative to help women in low and middle income countries gain the knowledge and confidence needed...

Yellow Wood Partners Agreed to Buy Dr. Scholl’s™ Business from Bayer

Yellow Wood Partners and Bayer announced that Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 585 million U.S. dollars...

Bayer Informed About the Establishment of Pyxis, Newly Formed Immuno-Oncology Company

lab research
Pyxis Oncology, a newly formed immuno-oncology company, launched with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor mic...

FDA Approved Bayer’s Gadavist™ Injection for Use in Cardiac Magnetic Resonance Imaging

fda
Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist™ (gadobutrol) injection for use in cardiac magnetic resonance imaging (CMRI) to assess myocardial perfusion and l...

Bayer, BMS and Ono in Clinical Collaboration Agreement

pills
Bayer, Bristol-Myers Squibb Company and Ono Pharmaceutical Co.,Ltd. (“Ono”) announced today that the three companies have entered into a clinical collaboration agreement to evaluate the combination of...

Climate FieldView, Industry-Leading Digital Farming Platform, Launched by Bayer in Argentina

bayer
The agriculture industry’s leading digital farming platform, Climate FieldView, has commercially launched in Argentina for the upcoming growing season. Already widely adopted globally, FieldView™ is t...

LEO Pharma Acquired Bayer’s Global Prescription Dermatology Business

LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies first announced...

Century Therapeutics Launched Allogeneic Cell Therapy Platform

Bayer
Century Therapeutics, a Versant Ventures-created company developing allogeneic or off-the-shelf immune cell therapies for cancer, emerged from stealth mode today with USD 250 million in financing comm...

Bayer’s Vet Med Received Positive Opinion for New Indications

Bayer's broadly active endectocide Advocate® Spot-on (imidacloprid/moxidectin) has now received, by consensus, the positive Opinion of the Committee for Medicinal Products for Veterinary Use (CVMP) of...

Bayer and AlphaBio Control Signed Agreement to Market Innovative Biological Pest Control

The choice of pest control products with different modes of action allows farmers worldwide to apply effective resistance management strategies. Bayer and AlphaBio Control have signed a distribution a...

German Federal Institute for Drugs and Medical Devices Reports Xarelto Counterfeits

counterfeit drug
Once again, two counterfeit batches of the drug Xarelto® 20 mg from the original manufacturer Bayer AG in Polish-Slovak packaging were discovered at a parallel distributor in Great Britain. Xarelt...

Bayer to Invest 5 billion Euros over the Next Decade to Combat Weeds

Bayer is raising the bar in transparency, sustainability and engagement, reflecting its heightened responsibility and potential as a new leader in agriculture. “We’re making good progress on integrat...